Published in Cancer Immunol Immunother on March 09, 2010
Interferon-lambda: a new addition to an old family. J Interferon Cytokine Res (2010) 2.15
IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production. J Exp Med (2015) 1.65
IFN-λs. Curr Opin Immunol (2011) 1.48
NK cells require IL-28R for optimal in vivo activity. Proc Natl Acad Sci U S A (2015) 1.14
Crystal structure of human interferon-λ1 in complex with its high-affinity receptor interferon-λR1. J Mol Biol (2010) 1.09
Interferon lambda: a new sword in cancer immunotherapy. Clin Dev Immunol (2011) 1.04
A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection. Gastroenterology (2011) 1.03
Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy. Acta Pharmacol Sin (2015) 0.92
Interferon-λ1 linked to a stabilized dimer of Fab potently enhances both antitumor and antiviral activities in targeted cells. PLoS One (2013) 0.85
Role of microRNA-15a in autoantibody production in interferon-augmented murine model of lupus. Mol Immunol (2012) 0.84
Role of interleukin-28B genetic polymorphisms in Korean patients with hepatitis C virus infection. Gut Liver (2013) 0.83
IL28B minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. J Gastroenterol (2013) 0.82
Comparison of the regulation of β-catenin signaling by type I, type II and type III interferons in hepatocellular carcinoma cells. PLoS One (2012) 0.79
IFN-λ cancer immunotherapy: new kid on the block. Immunotherapy (2016) 0.76
Concerted action of IFN-α and IFN-λ induces local NK cell immunity and halts cancer growth. Oncotarget (2016) 0.76
Mesenchymal stem cells are efficiently transduced with adenoviruses bearing type 35-derived fibers and the transduced cells with the IL-28A gene produces cytotoxicity to lung carcinoma cells co-cultured. BMC Cancer (2014) 0.76
Interleukin-29 Enhances Synovial Inflammation and Cartilage Degradation in Osteoarthritis. Mediators Inflamm (2016) 0.75
Adenovirus expressing IFN-λ (Ad/hIFN-λ) produced anti-tumor effects through inducing apoptosis in human tongue squamous cell carcinoma cell. Int J Clin Exp Med (2015) 0.75
Type III interferon attenuates a vesicular stomatitis virus-based vaccine vector. J Virol (2014) 0.75
Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A/IFN-λ2 or IL-29/IFN-λ1. Cancer Gene Ther (2016) 0.75
IFNλ Stimulates MxA Production in Human Dermal Fibroblasts via a MAPK-Dependent STAT1-Independent Mechanism. J Invest Dermatol (2015) 0.75
Contribution of Type III Interferons to Antiviral Immunity; Location, Location, Location. J Biol Chem (2017) 0.75
Replication and Oncolytic Activity of an Avian Orthoreovirus in Human Hepatocellular Carcinoma Cells. Viruses (2017) 0.75
Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma. Dig Dis Sci (2017) 0.75
Interleukin-28B TT genotype is frequently found in patients with hepatitis C virus cirrhosis but does not influence hepatocarcinogenesis. Clin Exp Med (2016) 0.75
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature (2009) 26.47
Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol (2003) 15.65
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet (2009) 14.16
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature (2009) 13.99
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet (2009) 13.03
IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol (2002) 11.87
IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol (2002) 11.22
Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer (2006) 10.05
Type I interferons in host defense. Immunity (2006) 7.32
Interferons, interferon-like cytokines, and their receptors. Immunol Rev (2004) 6.21
Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology (2006) 6.16
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol (2008) 5.93
Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. Science (1992) 5.71
Lambda interferon inhibits hepatitis B and C virus replication. J Virol (2005) 5.47
IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog (2008) 4.70
Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol (2006) 4.21
ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains. Proc Natl Acad Sci U S A (1990) 4.11
Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol (2002) 3.83
An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol (2008) 3.75
The yin and yang of type I interferon activity in bacterial infection. Nat Rev Immunol (2005) 3.65
Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology (2006) 3.46
Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis (2005) 2.98
Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int (2008) 2.65
The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev (2003) 2.62
Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog (2008) 2.38
Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma. Cancer Res (2006) 2.34
Biological activity of interleukins-28 and -29: comparison with type I interferons. Cytokine (2005) 2.27
A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol (1996) 2.24
Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes. Am J Pathol (2007) 2.18
Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol (1996) 2.14
Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma. J Hepatol (2006) 2.03
Interferon-alpha in tumor immunity and immunotherapy. Cytokine Growth Factor Rev (2002) 1.84
Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines. Genes Immun (2009) 1.81
Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood (2006) 1.76
Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity. Blood (2009) 1.75
Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP) Am J Gastroenterol (1998) 1.74
Modifications of vectors pEF-BOS, pcDNA1 and pcDNA3 result in improved convenience and expression. Biotechniques (1996) 1.69
Antitumor activity of IFN-lambda in murine tumor models. J Immunol (2006) 1.63
A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. Ann Surg (2007) 1.63
Recurrence of hepatocellular carcinoma. N Engl J Med (2008) 1.60
Side effects of alpha interferon in chronic hepatitis C. Hepatology (1997) 1.58
Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol (2008) 1.50
A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan. Antivir Ther (2006) 1.48
IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity. Cancer Biol Ther (2008) 1.45
IL-28 elicits antitumor responses against murine fibrosarcoma. J Immunol (2007) 1.35
Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets. J Virol (2009) 1.22
Hepatocellular carcinoma. Hepatology (1998) 1.16
Prevention of hepatocellular carcinoma and its recurrence in chronic hepatitis C patients by interferon therapy. Clin Gastroenterol Hepatol (2005) 1.12
Molecular prognostication of liver cancer: end of the beginning. J Hepatol (2006) 1.12
Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells. Virus Res (2007) 1.11
Hepatocellular carcinoma: molecular biology and therapy. Semin Oncol (2006) 1.10
Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma. Hepatology (2000) 1.10
Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Proc Natl Acad Sci U S A (2007) 1.08
Radiofrequency ablation and chemoembolization for hepatocellular carcinoma. Cancer J (2008) 1.06
Recombinant interferon-alpha in inoperable hepatocellular carcinoma: a randomized controlled trial. Hepatology (1993) 0.99
Therapeutic strategy of advanced hepatocellular carcinoma by using combined intra-arterial chemotherapy. Recent Pat Anticancer Drug Discov (2008) 0.91
Augmentation of antitumor immunity by tumor cells transduced with a retroviral vector carrying the interleukin-2 and interferon-gamma cDNAs. Blood (1994) 0.88
The role of IFN-gamma in rejection of established tumors by IL-12 : source of production and target. Cancer Res (2002) 0.85
Liver transplantation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg (2008) 0.80
Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology (2006) 6.16
Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med (2006) 5.90
The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J Leukoc Biol (2004) 2.81
Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. J Biol Chem (2004) 2.55
IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J Immunol (2007) 2.40
Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma. Cancer Res (2006) 2.34
Interferon-lambda: a new addition to an old family. J Interferon Cytokine Res (2010) 2.15
Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection. Hepatology (2010) 2.02
Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J Virol (2010) 1.66
Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. Environ Health Perspect (2002) 1.60
Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J Gen Virol (2005) 1.52
Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J Biol Chem (2001) 1.47
Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26. Eur J Immunol (2006) 1.45
IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease. EMBO Mol Med (2011) 1.44
Gamma-tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice. Int J Cancer (2009) 1.33
Sequence and phylogenetic analysis of nucleocapsid genes of porcine epidemic diarrhea virus (PEDV) strains in China. Arch Virol (2013) 1.29
Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2. J Immunol (2004) 1.28
Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus. J Virol (2006) 1.28
The role of transposable elements in the regulation of IFN-lambda1 gene expression. Proc Natl Acad Sci U S A (2009) 1.24
Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells. J Immunol (2012) 1.23
Interferon induction and function at the mucosal surface. Immunol Rev (2013) 1.15
Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells. Virus Res (2007) 1.11
Crystal structure of human interferon-λ1 in complex with its high-affinity receptor interferon-λR1. J Mol Biol (2010) 1.09
Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus. EMBO Mol Med (2012) 1.08
Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Proc Natl Acad Sci U S A (2007) 1.08
Interferon lambda: a new sword in cancer immunotherapy. Clin Dev Immunol (2011) 1.04
Cyclic adenosine monophosphate differentiated beta-endorphin neurons promote immune function and prevent prostate cancer growth. Proc Natl Acad Sci U S A (2008) 1.03
Brain injury expands the numbers of neural stem cells and progenitors in the SVZ by enhancing their responsiveness to EGF. ASN Neuro (2009) 1.01
Overview of monoclonal B-cell lymphocytosis. Br J Haematol (2007) 1.00
Characterization of the recombinant extracellular domains of human interleukin-20 receptors and their complexes with interleukin-19 and interleukin-20. Biochemistry (2003) 0.99
Usp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-λ and elevated secretion of Cxcl10. EMBO Mol Med (2013) 0.99
Inhibitory effect of 12-O-tetradecanoylphorbol-13-acetate alone or in combination with all-trans-retinoic acid on the growth of LNCaP prostate tumors in immunodeficient mice. Cancer Res (2004) 0.96
Chronic lymphocytic leukaemia genetics overview. Br J Haematol (2007) 0.95
Contribution of the Box 1 and Box 2 motifs of cytokine receptors to Jak1 association and activation. J Biol Chem (2002) 0.95
Dietary tocopherols inhibit cell proliferation, regulate expression of ERα, PPARγ, and Nrf2, and decrease serum inflammatory markers during the development of mammary hyperplasia. Mol Carcinog (2012) 0.93
Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model. Br J Haematol (2007) 0.92
The Golgi-Cox method. Methods Mol Biol (2013) 0.91
Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: implications for hematopoiesis, self-renewal and differentiation potential. Virology (2006) 0.90
Corpus callosum deficiency in transgenic mice expressing a truncated ephrin-A receptor. J Neurosci (2003) 0.89
Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA. J Immunol (2008) 0.88
Does high load of oxidants in human semen contribute to male factor infertility? Antioxid Redox Signal (2012) 0.87
Regulatory effects of ribosomal S6 kinase 1 (RSK1) in IFNλ signaling. J Biol Chem (2010) 0.87
Dietary phenethylisothiocyanate attenuates bowel inflammation in mice. BMC Chem Biol (2010) 0.87
A new member of the interleukin 10-related cytokine family encoded by a poxvirus. J Gen Virol (2004) 0.86
The effects of Di-(2-ethylhexyl)-phthalate exposure on fertilization and embryonic development in vitro and testicular genomic mutation in vivo. PLoS One (2012) 0.86
Role of oxidative stress and the mitochondrial permeability transition in methylmercury cytotoxicity. Neurotoxicology (2011) 0.86
Genistein induces G2 arrest in malignant B cells by decreasing IL-10 secretion. Cell Cycle (2004) 0.85
Abnormal hippocampal axon bundling in EphB receptor mutant mice. J Neurosci (2004) 0.85
Dietary administration of δ- and γ-tocopherol inhibits tumorigenesis in the animal model of estrogen receptor-positive, but not HER-2 breast cancer. Cancer Prev Res (Phila) (2012) 0.85
Adjunctive treatment of disseminated Mycobacterium avium complex infection with interferon alpha-2b in a patient with complete interferon-gamma receptor R1 deficiency. Eur J Pediatr (2006) 0.85
Role of microRNA-15a in autoantibody production in interferon-augmented murine model of lupus. Mol Immunol (2012) 0.84
Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patients. Transplantation (2002) 0.84
Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor-β-mediated growth inhibition. Pigment Cell Melanoma Res (2011) 0.84
Pentoxifylline inhibits liver expression of tumor necrosis factor alpha mRNA following normothermic ischemia-reperfusion. HPB (Oxford) (2007) 0.83
Reproductive effects of two neonicotinoid insecticides on mouse sperm function and early embryonic development in vitro. PLoS One (2013) 0.83
The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia. Cytometry B Clin Cytom (2010) 0.82
Mixed tocotrienols inhibit prostate carcinogenesis in TRAMP mice. Nutr Cancer (2010) 0.82
Oxidized LDL induces apoptosis of human retinal pigment epithelium through activation of ERK-Bax/Bcl-2 signaling pathways. Curr Eye Res (2014) 0.81
B-cell repertoire and clonal analysis in unaffected first degree relatives in familial chronic lymphocytic leukaemia kindred. Br J Haematol (2007) 0.80
Egr-1 is a critical regulator of EGF-receptor-mediated expansion of subventricular zone neural stem cells and progenitors during recovery from hypoxia-hypoglycemia. ASN Neuro (2013) 0.79
Correlation of ZAP-70 expression in B cell leukemias to the ex vivo response to a combination of fludarabine/genistein. Cancer Immunol Immunother (2006) 0.79
RNA interference of IL-10 in leukemic B-1 cells. Cancer Immun (2004) 0.78
MicroRNAs in Acute Myeloid Leukemia and Other Blood Disorders. Leuk Res Treatment (2012) 0.78
Non-canonical Smads phosphorylation induced by the glutamate release inhibitor, riluzole, through GSK3 activation in melanoma. PLoS One (2012) 0.77
Effect of mifepristone on uterine receptivity in guinea pigs. Acta Pharmacol Sin (2002) 0.77
Critical role of the endogenous interferon ligand-receptors in type I and type II interferons response. Immunology (2014) 0.76
MicroRNAs and induced pluripotent stem cells for human disease mouse modeling. J Biomed Biotechnol (2012) 0.76
A sperm viability test using SYBR-14/propidium iodide flow cytometry as a tool for rapid screening of primary ciliary dyskinesia patients and for choosing sperm sources for intracytoplasmic sperm injection. Fertil Steril (2010) 0.76
[Impact of cigarette smoking on human sperm DNA integrity]. Zhonghua Nan Ke Xue (2010) 0.76
Another functional frame-shift polymorphism of DEFB126 (rs11467497) associated with male infertility. J Cell Mol Med (2015) 0.75
Correction: Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections. PLoS Pathog (2016) 0.75
[Breakpoints located by sequence tagged sites of AZFc microdeletion in Chinese Han population]. Zhonghua Nan Ke Xue (2012) 0.75
[Polyclonal antibody production and immunoassay development for detection of beta-lactamase in milk]. Wei Sheng Yan Jiu (2013) 0.75